tirzepatide stronger than semaglutide and key differences, weight loss results (2026) Semaglutide vs Tirzepatide: Which GLP-1

Journal of the ASEAN Federation of Endocrine Societies, 37 (2), 6572

The platform does not override medical discretion or alter eligibility thresholds

Tirzepatide may carry a slightly higher incidence of gastrointestinal symptoms initially because its dual-receptor activation is more potent, but severity typically decreases with dose titration and consistent use

Mechanistic studies examining the pathways related to GLP-1RA use with vestibular dysfunction are needed, particularly the role of GIP co-agonism in decreasing vestibular risk

Growth hormone (22 kDa), insulin (5.8 kDa but with poor sublingual permeability due to structure), and most antibody fragments (25-50 kDa) fall into this category

Dosing is individualized based on response and side effects, often starting at lower doses than those used in transplant patients